Shanghai – April 16, 2018 – Cooley advised Qiming Venture Partners on the closing of its sixth family of venture capital funds, Qiming Venture Partners VI, with total commitments of $935 million. Cooley partner Jordan Silber led the team advising Qiming.
Since its debut, Qiming has backed 200+ young, fast-growing and innovative companies across China in the internet and consumer, healthcare, information technology and clean technology sectors. More than 30 of Qiming’s investments are listed on the public markets, including NYSE, Nasdaq, HKEx, Gretai Securities Market, Shanghai Stock Exchange and Shenzhen Stock Exchange, or have exited through M&A transactions.
Many of Qiming’s portfolio companies are today’s most influential brands in their respective sectors, including Xiaomi, Dianping, iTutorGroup, Mogujie, Meitu, Bilibili, Tigermed, Gan & Lee, Zai Lab, Hexing, CSD, Tellgen, AmoyDx, HyperStrong, We Doctor Group, Face++, UBTech and Mobike. Qiming consistently ranks among the top venture firms for its ROI.
Cooley has been advising Qiming Venture for more than five years, assisting in fund formation and financing transactions. The firm is fund formation counsel to 550+ fund organizations worldwide, including 50+ fund managers with their primary operations in China.
About Cooley LLP
Clients partner with Cooley on transformative deals, complex IP and regulatory matters, and high-stakes litigation, where innovation meets the law.
Cooley has 900+ lawyers across 13 offices in the United States, China and Europe.